APTOF Projected Dividend Yield

Aptose Biosciences Inc ( OTCBB : APTOF )

Aptose Biosciences is a clinical-stage biotechnology company focused on developing precision medicines for oncology, particularly hematology. Its pipeline includes small molecule cancer therapeutics designed for single-agent efficacy and to enhance other anti-cancer therapies without overlapping toxicities. The lead compound, Tuspetinib, is an oral kinase inhibitor showing activity as a monotherapy and in combination for relapsed or refractory acute myeloid leukemia (AML), and is being developed for newly diagnosed AML. Luxeptinib targets B-cell malignancies like chronic lymphocytic leukemia, and certain non-Hodgkin's lymphomas resistant to conventional treatments.

21 YEAR PERFORMANCE RESULTS

APTOF Dividend History Detail
APTOF Dividend News
APTOF Competitors News
# of Shares: 0 Closing Price: 1.50 Current Market Value: 0.00 Cost Basis: 0.00 Date Acquired:
Dividend Cash Flow
Year Annual Dividend Dividend Growth # of Shares Annual Dividend Income Yield On Cost %
2014 0.00 0% 0 $ 0.00 0.00%
2015 0.00 0% 0 $ 0.00 0.00%
2016 0.00 0% 0 $ 0.00 0.00%
2017 0.00 0% 0 $ 0.00 0.00%
2018 0.00 0% 0 $ 0.00 0.00%
2019 0.00 0% 0 $ 0.00 0.00%
2020 0.00 0% 0 $ 0.00 0.00%
2021 0.00 0% 0 $ 0.00 0.00%
2022 0.00 0% 0 $ 0.00 0.00%
2023 0.00 0% 0 $ 0.00 0.00%
2024 0.00 0% 0 $ 0.00 0.00%
2025 0.00 0% 0 $ 0.00 0.00%
2026 0.00 0% 0 $ 0.00 0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection)
0.00
Year
Declaration Date
Ex-Dividend Date
Record Date
Payable Date
Dividend $ Amount
Total:
0.0000
X
Search Dividend Investor